TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk A/S
Closing information (x1000 SEK)
| Closing information | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Turnover |
0
|
0
|
147,775,268 |
| Financial expenses | 2,028,179 | ||
| Earnings before taxes |
67,818,330
|
65,518,368
|
64,404,276 |
| Total assets |
175,453,547
|
152,418,441
|
135,417,003 |
| Current assets |
87,237,897
|
81,276,350
|
79,486,625 |
| Current liabilities |
82,386,847
|
74,529,809
|
62,255,703 |
| Equity capital |
80,445,309
|
71,330,603
|
65,905,896 |
| - share capital |
670,459
|
674,241
|
661,507 |
| Employees (average) |
1,000
|
1,000
|
42,682 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Solvency |
45.8%
|
46.8%
|
48.7% |
| Turnover per employee |
0
|
0
|
3,462 |
| Profit as a percentage of turnover | 43.6% | ||
| Return on assets (ROA) | 49.1% | ||
| Current ratio |
105.9%
|
109.1%
|
127.7% |
| Return on equity (ROE) |
84.3%
|
91.9%
|
97.7% |
| Change turnover |
0
|
-153,693,995
|
-111,133 |
| Change turnover % | 0% | ||
| Chg. No. of employees |
0
|
-41,682
|
236 |
| Chg. No. of employees % | 0% | 1% |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.